Issue 6, 2005

Natural products to drugs: daptomycin and related lipopeptide antibiotics

Abstract

Covering: 1953 to September 2005

Daptomycin (Cubicin®) is a lipopeptide antibiotic approved in the USA in 2003 for the treatment of skin and skin structure infections caused by Gram-positive pathogens. It is a member of the 10-membered cyclic lipopeptide family of antibiotics that includes A54145, calcium-dependent antibiotic (CDA), amphomycin, friulimicin, laspartomycin, and others. This review highlights research on this class of antibiotics from 1953 to 2005, focusing on more recent studies with particular emphasis on the interplay between structural features and antibacterial activities; chemical modifications to improve activity; the genetic organization and biosynthesis of lipopeptides; and the genetic engineering of the daptomycin biosynthetic pathway to produce novel derivatives for further chemical modification to develop candidates for clinical evaluation.

Graphical abstract: Natural products to drugs: daptomycin and related lipopeptide antibiotics

Article information

Article type
Review Article
Submitted
28 Sep 2005
First published
04 Nov 2005

Nat. Prod. Rep., 2005,22, 717-741

Natural products to drugs: daptomycin and related lipopeptide antibiotics

R. H. Baltz, V. Miao and S. K. Wrigley, Nat. Prod. Rep., 2005, 22, 717 DOI: 10.1039/B416648P

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements